Publications, Pharmaceutical

Aptar Pharma Q&A on trends and challenges in nasal drug delivery

Nasal drug delivery is currently the focus of considerable drug development activity.

This Q&A takes a detailed look at the nasal drug delivery landscape and the potential of this route for the delivery of vaccines and therapeutics for COVID-19, for nose-to-brain drug delivery and for improving the accessibility of emergency medications. Key challenges associated with the development of nasal drug products are outlined along with factors impacting device design and selection.
The regulatory landscape is also considered. Barriers to the development of nasal drug delivery products are examined but it is concluded that the route has a bright future with considerable potential to address currently unmet therapeutic needs.

Download the Q&A
Author(s): Dr Julie D. Suman
21 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

28 Jan 2022

Improving Intranasal Sprays for Respiratory Viral Infections

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation

Read More
22 Dec 2021

The Go-To Drug Delivery Expert

Brochures, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions, Sustainability

Read More
22 Dec 2021

End-To-End Support at Every Stage of Your Drug Development Journey

Brochures, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation

Read More
13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital Health

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 … 14 15 16 17 18 … 27

Request Access

Close

Requesting access to Aptar Pharma Q&A on trends and challenges in nasal drug delivery.

  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top